ANDA 72924, held by Watson Labs. Verapamil Hydrochloride.
As of Nov 16, 2026, ANDA 72924 (Verapamil Hydrochloride), held by Watson Labs, was first approved by FDA on Jun 29, 1993, with 11 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory bypass tract ) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia Essential hypertension: Verapamil is indicated for the treatment of hypertension, to lower blood pressure.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Verapamil Hydrochloride40MG · tablet;oral | Verapamil Hydrochloride | Rx |
| Oct 26, 2015 | Supplement 20Labeling · Standard review | Approved | None posted |
| Nov 26, 2012 | Supplement 19Labeling · Standard review | Approved | None posted |
| Apr 19, 2007 | Supplement 12Manufacturing | Approved | None posted |
| Nov 7, 2002 | Supplement 9Manufacturing | Approved | None posted |
| Jun 25, 2002 | Supplement 8Manufacturing | Approved | None posted |
| May 21, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Sep 5, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Nov 10, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Aug 26, 1998 | Supplement 3Labeling | Approved | None posted |
| Apr 10, 1996 | Supplement 2Labeling | Approved | None posted |
| Jan 27, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Jun 29, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters